283 related articles for article (PubMed ID: 22056688)
1. Cerebral microbleeds: burden assessment by using quantitative susceptibility mapping.
Liu T; Surapaneni K; Lou M; Cheng L; Spincemaille P; Wang Y
Radiology; 2012 Jan; 262(1):269-78. PubMed ID: 22056688
[TBL] [Abstract][Full Text] [Related]
2. Improved subthalamic nucleus depiction with quantitative susceptibility mapping.
Liu T; Eskreis-Winkler S; Schweitzer AD; Chen W; Kaplitt MG; Tsiouris AJ; Wang Y
Radiology; 2013 Oct; 269(1):216-23. PubMed ID: 23674786
[TBL] [Abstract][Full Text] [Related]
3. Quantifying cerebral microbleeds using quantitative susceptibility mapping from magnetization-prepared rapid gradient-echo.
Naji N; Gee M; Jickling GC; Emery DJ; Saad F; McCreary CR; Smith EE; Camicioli R; Wilman AH
NMR Biomed; 2024 Mar; ():e5139. PubMed ID: 38465729
[TBL] [Abstract][Full Text] [Related]
4. Hematoma volume measurement in gradient echo MRI using quantitative susceptibility mapping.
Wang S; Lou M; Liu T; Cui D; Chen X; Wang Y
Stroke; 2013 Aug; 44(8):2315-7. PubMed ID: 23704111
[TBL] [Abstract][Full Text] [Related]
5. Two-Minute Quantitative Susceptibility Mapping From Three-Dimensional Echo-Planar Imaging: Accuracy, Reliability, and Detection Performance in Patients With Cerebral Microbleeds.
Wicaksono KP; Fushimi Y; Nakajima S; Yokota Y; Oshima S; Otani S; Sakurama A; Shima A; Sawamoto N; Okada T; Nakamoto Y
Invest Radiol; 2021 Feb; 56(2):69-77. PubMed ID: 32649332
[TBL] [Abstract][Full Text] [Related]
6. Comparison of quantitative susceptibility mapping methods on evaluating radiation-induced cerebral microbleeds and basal ganglia at 3T and 7T.
Chen Y; Genc O; Poynton CB; Banerjee S; Hess CP; Lupo JM
NMR Biomed; 2022 May; 35(5):e4666. PubMed ID: 35075701
[TBL] [Abstract][Full Text] [Related]
7. Quantitative susceptibility mapping improves cerebral microbleed detection relative to susceptibility-weighted images.
Lee K; Ellison B; Selim M; Long NH; Filippidis A; Thomas AJ; Spincemaille P; Wang Y; Soman S
J Neuroimaging; 2023 Jan; 33(1):138-146. PubMed ID: 36168880
[TBL] [Abstract][Full Text] [Related]
8. Imaging Cerebral Microhemorrhages in Military Service Members with Chronic Traumatic Brain Injury.
Liu W; Soderlund K; Senseney JS; Joy D; Yeh PH; Ollinger J; Sham EB; Liu T; Wang Y; Oakes TR; Riedy G
Radiology; 2016 Feb; 278(2):536-45. PubMed ID: 26371749
[TBL] [Abstract][Full Text] [Related]
9. Quantitative susceptibility mapping (QSM) as a means to monitor cerebral hematoma treatment.
Zhang Y; Wei H; Sun Y; Cronin MJ; He N; Xu J; Zhou Y; Liu C
J Magn Reson Imaging; 2018 Oct; 48(4):907-915. PubMed ID: 29380461
[TBL] [Abstract][Full Text] [Related]
10. Cerebral MR oximetry during acetazolamide augmentation: Beyond cerebrovascular reactivity in hemodynamic failure.
Leatherday C; Dehkharghani S; Nahab F; Allen JW; Wu J; Hu R; Qiu D
J Magn Reson Imaging; 2019 Jul; 50(1):175-182. PubMed ID: 30390367
[TBL] [Abstract][Full Text] [Related]
11. Cerebral microbleeds: accelerated 3D T2*-weighted GRE MR imaging versus conventional 2D T2*-weighted GRE MR imaging for detection.
Vernooij MW; Ikram MA; Wielopolski PA; Krestin GP; Breteler MM; van der Lugt A
Radiology; 2008 Jul; 248(1):272-7. PubMed ID: 18490493
[TBL] [Abstract][Full Text] [Related]
12. Exploring the origins of echo-time-dependent quantitative susceptibility mapping (QSM) measurements in healthy tissue and cerebral microbleeds.
Cronin MJ; Wang N; Decker KS; Wei H; Zhu WZ; Liu C
Neuroimage; 2017 Apr; 149():98-113. PubMed ID: 28126551
[TBL] [Abstract][Full Text] [Related]
13. Rapid quantitative susceptibility mapping of intracerebral hemorrhage.
De A; Sun H; Emery DJ; Butcher KS; Wilman AH
J Magn Reson Imaging; 2020 Mar; 51(3):712-718. PubMed ID: 31276278
[TBL] [Abstract][Full Text] [Related]
14. Visualization of cerebral microbleeds with dual-echo T2*-weighted magnetic resonance imaging at 7.0 T.
Conijn MM; Geerlings MI; Luijten PR; Zwanenburg JJ; Visser F; Biessels GJ; Hendrikse J
J Magn Reson Imaging; 2010 Jul; 32(1):52-9. PubMed ID: 20578010
[TBL] [Abstract][Full Text] [Related]
15. Intracranial calcifications and hemorrhages: characterization with quantitative susceptibility mapping.
Chen W; Zhu W; Kovanlikaya I; Kovanlikaya A; Liu T; Wang S; Salustri C; Wang Y
Radiology; 2014 Feb; 270(2):496-505. PubMed ID: 24126366
[TBL] [Abstract][Full Text] [Related]
16. STrategically Acquired Gradient Echo (STAGE) imaging, part I: Creating enhanced T1 contrast and standardized susceptibility weighted imaging and quantitative susceptibility mapping.
Chen Y; Liu S; Wang Y; Kang Y; Haacke EM
Magn Reson Imaging; 2018 Feb; 46():130-139. PubMed ID: 29056394
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping.
Tan H; Liu T; Wu Y; Thacker J; Shenkar R; Mikati AG; Shi C; Dykstra C; Wang Y; Prasad PV; Edelman RR; Awad IA
Invest Radiol; 2014 Jul; 49(7):498-504. PubMed ID: 24619210
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
[TBL] [Abstract][Full Text] [Related]
19. Multi-centre, multi-vendor reproducibility of 7T QSM and R
Rua C; Clarke WT; Driver ID; Mougin O; Morgan AT; Clare S; Francis S; Muir KW; Wise RG; Carpenter TA; Williams GB; Rowe JB; Bowtell R; Rodgers CT
Neuroimage; 2020 Dec; 223():117358. PubMed ID: 32916289
[TBL] [Abstract][Full Text] [Related]
20. 2D harmonic filtering of MR phase images in multicenter clinical setting: toward a magnetic signature of cerebral microbleeds.
Kaaouana T; de Rochefort L; Samaille T; Thiery N; Dufouil C; Delmaire C; Dormont D; Chupin M
Neuroimage; 2015 Jan; 104():287-300. PubMed ID: 25149849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
